 David Orlicky
Concepts (903)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 47 | 2023 | 1630 | 2.390 |
Why?
| | Cholestasis | 12 | 2023 | 227 | 1.730 |
Why?
| | Mice | 118 | 2023 | 14679 | 1.570 |
Why?
| | Pelvic Organ Prolapse | 3 | 2023 | 39 | 1.550 |
Why?
| | Non-alcoholic Fatty Liver Disease | 10 | 2022 | 244 | 1.530 |
Why?
| | Ethanol | 19 | 2023 | 532 | 1.510 |
Why?
| | Lipid Metabolism | 18 | 2020 | 438 | 1.500 |
Why?
| | Animals | 166 | 2023 | 31162 | 1.370 |
Why?
| | Hepatocytes | 9 | 2023 | 196 | 1.340 |
Why?
| | Liver Diseases, Alcoholic | 10 | 2022 | 81 | 1.250 |
Why?
| | Perilipin-2 | 13 | 2019 | 36 | 1.230 |
Why?
| | Mice, Inbred C57BL | 55 | 2023 | 4617 | 1.140 |
Why?
| | Ligaments | 3 | 2023 | 45 | 1.040 |
Why?
| | Oxidative Stress | 23 | 2022 | 1065 | 1.030 |
Why?
| | Obesity | 15 | 2023 | 2501 | 0.980 |
Why?
| | Receptors, Prostaglandin | 13 | 1998 | 22 | 0.980 |
Why?
| | Fatty Liver | 12 | 2021 | 209 | 0.950 |
Why?
| | Dinoprost | 15 | 1996 | 30 | 0.900 |
Why?
| | Acetaminophen | 6 | 2022 | 241 | 0.860 |
Why?
| | Metabolic Syndrome | 7 | 2023 | 317 | 0.840 |
Why?
| | Fatty Liver, Alcoholic | 5 | 2021 | 14 | 0.830 |
Why?
| | Mice, Knockout | 35 | 2023 | 2523 | 0.820 |
Why?
| | Uterus | 4 | 2020 | 191 | 0.810 |
Why?
| | Bile Acids and Salts | 9 | 2023 | 171 | 0.770 |
Why?
| | Adipocytes | 6 | 2018 | 185 | 0.740 |
Why?
| | Fructose | 9 | 2023 | 100 | 0.740 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2017 | 102 | 0.720 |
Why?
| | Receptors, Estrogen | 2 | 2023 | 371 | 0.710 |
Why?
| | Fructokinases | 8 | 2023 | 29 | 0.710 |
Why?
| | Cytoplasm | 6 | 2016 | 246 | 0.700 |
Why?
| | Disease Models, Animal | 30 | 2023 | 3470 | 0.690 |
Why?
| | Sacrum | 1 | 2020 | 62 | 0.680 |
Why?
| | Aldehydes | 10 | 2022 | 137 | 0.670 |
Why?
| | Protein Carbonylation | 8 | 2018 | 51 | 0.660 |
Why?
| | Milk | 7 | 2019 | 123 | 0.640 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.630 |
Why?
| | Dietary Fats | 5 | 2022 | 286 | 0.610 |
Why?
| | Skin | 9 | 2019 | 650 | 0.600 |
Why?
| | Liver Diseases | 5 | 2023 | 254 | 0.590 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 4 | 2021 | 192 | 0.590 |
Why?
| | Chemical Warfare Agents | 6 | 2014 | 119 | 0.590 |
Why?
| | Kidney | 8 | 2019 | 1179 | 0.580 |
Why?
| | Chemical and Drug Induced Liver Injury | 5 | 2022 | 125 | 0.580 |
Why?
| | NF-kappa B | 6 | 2023 | 615 | 0.570 |
Why?
| | Antioxidants | 10 | 2023 | 527 | 0.560 |
Why?
| | Neoplasm Proteins | 9 | 2005 | 381 | 0.560 |
Why?
| | Mechlorethamine | 5 | 2015 | 63 | 0.550 |
Why?
| | Membrane Proteins | 12 | 2016 | 1008 | 0.550 |
Why?
| | Lactation | 10 | 2019 | 147 | 0.540 |
Why?
| | Diet, High-Fat | 9 | 2020 | 224 | 0.520 |
Why?
| | Mammary Glands, Animal | 7 | 2019 | 116 | 0.520 |
Why?
| | Organelles | 2 | 2013 | 51 | 0.510 |
Why?
| | Cholangitis, Sclerosing | 3 | 2023 | 66 | 0.500 |
Why?
| | Parenteral Nutrition | 5 | 2023 | 95 | 0.500 |
Why?
| | Glutathione Transferase | 6 | 2019 | 91 | 0.500 |
Why?
| | Mitochondria | 6 | 2019 | 735 | 0.490 |
Why?
| | PTEN Phosphohydrolase | 4 | 2018 | 140 | 0.460 |
Why?
| | Ovary | 4 | 2022 | 189 | 0.460 |
Why?
| | Male | 67 | 2023 | 55112 | 0.440 |
Why?
| | Inflammation | 16 | 2023 | 2444 | 0.440 |
Why?
| | DNA Damage | 7 | 2021 | 345 | 0.430 |
Why?
| | Alcohol Drinking | 4 | 2016 | 651 | 0.430 |
Why?
| | Prostaglandins F | 6 | 1988 | 17 | 0.420 |
Why?
| | Peptides | 3 | 2008 | 844 | 0.410 |
Why?
| | Down Syndrome | 3 | 2023 | 335 | 0.400 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 59 | 0.390 |
Why?
| | Receptors, Virus | 2 | 2003 | 75 | 0.390 |
Why?
| | Superoxide Dismutase | 6 | 2019 | 302 | 0.390 |
Why?
| | Transfection | 8 | 2016 | 842 | 0.370 |
Why?
| | Fructose Intolerance | 2 | 2023 | 3 | 0.370 |
Why?
| | Adenoviridae | 2 | 2003 | 179 | 0.370 |
Why?
| | Mustard Gas | 5 | 2014 | 117 | 0.360 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.360 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 283 | 0.360 |
Why?
| | Energy Metabolism | 5 | 2019 | 717 | 0.350 |
Why?
| | Lens, Crystalline | 2 | 2022 | 90 | 0.350 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2017 | 158 | 0.350 |
Why?
| | Endometrium | 6 | 1988 | 60 | 0.350 |
Why?
| | Burns | 2 | 2023 | 232 | 0.340 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2023 | 210 | 0.340 |
Why?
| | Glutathione Reductase | 3 | 2019 | 20 | 0.340 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 24 | 0.340 |
Why?
| | Precancerous Conditions | 2 | 2023 | 153 | 0.330 |
Why?
| | Signal Transduction | 14 | 2022 | 4439 | 0.330 |
Why?
| | Carcinoma, Basal Cell | 2 | 2022 | 67 | 0.330 |
Why?
| | Thioredoxins | 3 | 2018 | 33 | 0.330 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2014 | 170 | 0.330 |
Why?
| | Lipids | 7 | 2019 | 558 | 0.320 |
Why?
| | Rats | 18 | 2022 | 4829 | 0.320 |
Why?
| | Female | 55 | 2023 | 59115 | 0.320 |
Why?
| | Lung Injury | 2 | 2021 | 192 | 0.310 |
Why?
| | Immunity, Innate | 5 | 2023 | 716 | 0.310 |
Why?
| | Ultraviolet Rays | 4 | 2022 | 357 | 0.310 |
Why?
| | Colitis | 2 | 2021 | 220 | 0.310 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2293 | 0.310 |
Why?
| | Fallopian Tubes | 2 | 2022 | 29 | 0.310 |
Why?
| | Taste | 2 | 2021 | 208 | 0.310 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2021 | 270 | 0.310 |
Why?
| | Sevelamer | 2 | 2020 | 9 | 0.310 |
Why?
| | Humans | 63 | 2023 | 113531 | 0.310 |
Why?
| | Skin Neoplasms | 3 | 2022 | 755 | 0.300 |
Why?
| | Lung | 7 | 2022 | 3497 | 0.290 |
Why?
| | Macrophages | 6 | 2021 | 1233 | 0.290 |
Why?
| | Leptin | 2 | 2020 | 207 | 0.290 |
Why?
| | Hibernation | 2 | 2023 | 72 | 0.290 |
Why?
| | Liver Neoplasms | 2 | 2023 | 504 | 0.290 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 5 | 2020 | 22 | 0.290 |
Why?
| | Epithelial Cells | 7 | 2022 | 939 | 0.280 |
Why?
| | Kidney Diseases | 2 | 2023 | 348 | 0.280 |
Why?
| | RNA, Messenger | 12 | 2023 | 2507 | 0.280 |
Why?
| | Genetic Vectors | 4 | 2010 | 285 | 0.270 |
Why?
| | Lipid Peroxidation | 5 | 2014 | 138 | 0.270 |
Why?
| | Triglycerides | 8 | 2021 | 464 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 394 | 0.260 |
Why?
| | HEK293 Cells | 5 | 2021 | 585 | 0.260 |
Why?
| | Lipid Droplets | 4 | 2019 | 21 | 0.260 |
Why?
| | Blister | 4 | 2014 | 43 | 0.250 |
Why?
| | Mice, Hairless | 9 | 2017 | 74 | 0.250 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 209 | 0.250 |
Why?
| | Irritants | 2 | 2017 | 41 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2022 | 486 | 0.250 |
Why?
| | Diet, Western | 3 | 2022 | 66 | 0.250 |
Why?
| | Glycoproteins | 4 | 2021 | 302 | 0.250 |
Why?
| | Pancreatic Neoplasms | 4 | 2020 | 721 | 0.250 |
Why?
| | I-kappa B Proteins | 2 | 2022 | 75 | 0.250 |
Why?
| | Aldehyde Oxidoreductases | 3 | 2010 | 29 | 0.240 |
Why?
| | Endoplasmic Reticulum | 5 | 2019 | 233 | 0.240 |
Why?
| | Transduction, Genetic | 3 | 2003 | 112 | 0.240 |
Why?
| | Liver Cirrhosis | 5 | 2023 | 226 | 0.240 |
Why?
| | Colon | 3 | 2023 | 228 | 0.240 |
Why?
| | Dioxanes | 2 | 2021 | 5 | 0.240 |
Why?
| | Immunohistochemistry | 12 | 2018 | 1604 | 0.240 |
Why?
| | Glycine | 2 | 2016 | 151 | 0.230 |
Why?
| | Oxygen | 3 | 2018 | 827 | 0.230 |
Why?
| | Cell Line | 14 | 2022 | 2581 | 0.230 |
Why?
| | Protein Processing, Post-Translational | 4 | 2017 | 394 | 0.230 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2023 | 1106 | 0.230 |
Why?
| | Silymarin | 2 | 2016 | 194 | 0.230 |
Why?
| | Dietary Sucrose | 2 | 2023 | 45 | 0.220 |
Why?
| | Gene Deletion | 4 | 2018 | 351 | 0.220 |
Why?
| | Proteomics | 5 | 2021 | 808 | 0.220 |
Why?
| | Glycolipids | 2 | 2016 | 35 | 0.220 |
Why?
| | Lipoproteins | 2 | 2021 | 157 | 0.220 |
Why?
| | Glutathione | 7 | 2021 | 291 | 0.220 |
Why?
| | Digestive System Diseases | 1 | 2023 | 23 | 0.220 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2018 | 575 | 0.220 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 212 | 0.220 |
Why?
| | Autophagy | 3 | 2022 | 235 | 0.220 |
Why?
| | Azotemia | 1 | 2023 | 6 | 0.220 |
Why?
| | High Fructose Corn Syrup | 1 | 2023 | 7 | 0.210 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 154 | 0.210 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 33 | 0.210 |
Why?
| | Patched-1 Receptor | 2 | 2022 | 15 | 0.210 |
Why?
| | Alprostadil | 4 | 1992 | 31 | 0.210 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 234 | 0.210 |
Why?
| | Cell Membrane | 5 | 2016 | 663 | 0.210 |
Why?
| | Alcoholism | 2 | 2022 | 704 | 0.210 |
Why?
| | Torpor | 1 | 2023 | 14 | 0.210 |
Why?
| | Corpus Luteum | 4 | 1992 | 19 | 0.210 |
Why?
| | Weight Gain | 4 | 2019 | 454 | 0.210 |
Why?
| | Membrane Glycoproteins | 4 | 2021 | 420 | 0.210 |
Why?
| | Antidotes | 2 | 2015 | 135 | 0.210 |
Why?
| | Phospholipids | 2 | 2017 | 192 | 0.210 |
Why?
| | Cell Proliferation | 11 | 2020 | 2164 | 0.210 |
Why?
| | Mast Cells | 4 | 2019 | 117 | 0.210 |
Why?
| | Catalase | 3 | 2017 | 118 | 0.210 |
Why?
| | Proteins | 6 | 2013 | 890 | 0.210 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 377 | 0.210 |
Why?
| | Dermatitis, Contact | 2 | 2013 | 23 | 0.200 |
Why?
| | Nucleotides | 2 | 2021 | 111 | 0.200 |
Why?
| | Phosphorylation | 6 | 2020 | 1537 | 0.200 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 121 | 0.200 |
Why?
| | Endotoxemia | 1 | 2023 | 86 | 0.200 |
Why?
| | Abdominal Injuries | 1 | 2023 | 107 | 0.200 |
Why?
| | Receptors, Androgen | 1 | 2023 | 131 | 0.200 |
Why?
| | Thermogenesis | 2 | 2019 | 36 | 0.190 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 38 | 0.190 |
Why?
| | Energy Intake | 3 | 2021 | 424 | 0.190 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 210 | 0.190 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 13 | 0.190 |
Why?
| | Blotting, Western | 9 | 2015 | 1128 | 0.190 |
Why?
| | Estrogens | 2 | 2023 | 311 | 0.190 |
Why?
| | Apoptosis | 10 | 2020 | 2288 | 0.190 |
Why?
| | Glucose | 4 | 2023 | 894 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 337 | 0.190 |
Why?
| | Biomarkers | 7 | 2023 | 3389 | 0.190 |
Why?
| | Isoxazoles | 1 | 2021 | 51 | 0.190 |
Why?
| | Bacterial Toxins | 1 | 2022 | 103 | 0.190 |
Why?
| | Phytosterols | 1 | 2021 | 11 | 0.190 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 41 | 0.190 |
Why?
| | Biomarkers, Tumor | 3 | 2016 | 1029 | 0.190 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 81 | 0.190 |
Why?
| | Drug Resistance | 1 | 2022 | 158 | 0.190 |
Why?
| | Tandem Mass Spectrometry | 6 | 2022 | 405 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 91 | 0.180 |
Why?
| | Adrenal Glands | 1 | 2021 | 62 | 0.180 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 71 | 0.180 |
Why?
| | Fatty Acids | 4 | 2022 | 380 | 0.180 |
Why?
| | Eye | 1 | 2022 | 96 | 0.180 |
Why?
| | Peroxiredoxins | 2 | 2018 | 23 | 0.180 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2022 | 193 | 0.180 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 18 | 0.180 |
Why?
| | 3T3 Cells | 4 | 2003 | 133 | 0.180 |
Why?
| | Quinolines | 1 | 2022 | 127 | 0.180 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 23 | 0.180 |
Why?
| | Hepatitis | 2 | 2019 | 46 | 0.180 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 30 | 0.180 |
Why?
| | Mucoproteins | 1 | 2020 | 10 | 0.180 |
Why?
| | Azetidines | 1 | 2020 | 31 | 0.180 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2016 | 54 | 0.180 |
Why?
| | Vasopressins | 1 | 2021 | 56 | 0.180 |
Why?
| | Momordica charantia | 1 | 2020 | 13 | 0.180 |
Why?
| | Kidney Tubules | 2 | 2019 | 107 | 0.180 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 32 | 0.180 |
Why?
| | Uric Acid | 1 | 2021 | 148 | 0.170 |
Why?
| | Microtubule-Associated Proteins | 4 | 2019 | 170 | 0.170 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 15 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 182 | 0.170 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2016 | 305 | 0.170 |
Why?
| | Case-Control Studies | 4 | 2020 | 2993 | 0.170 |
Why?
| | Carcinogens | 2 | 2013 | 101 | 0.170 |
Why?
| | Protein Biosynthesis | 3 | 2001 | 375 | 0.170 |
Why?
| | Gene Expression | 2 | 2023 | 1397 | 0.170 |
Why?
| | Monocytes | 2 | 2021 | 499 | 0.170 |
Why?
| | Sugars | 1 | 2020 | 29 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 124 | 0.170 |
Why?
| | Melanocytes | 1 | 2020 | 54 | 0.170 |
Why?
| | Herpesviridae Infections | 1 | 2021 | 136 | 0.170 |
Why?
| | Adipose Tissue | 3 | 2019 | 537 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 54 | 0.170 |
Why?
| | Myometrium | 1 | 2020 | 35 | 0.170 |
Why?
| | PPAR alpha | 3 | 2016 | 52 | 0.170 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1140 | 0.170 |
Why?
| | Up-Regulation | 6 | 2022 | 794 | 0.170 |
Why?
| | Cytokines | 5 | 2022 | 1795 | 0.170 |
Why?
| | Cholesterol | 5 | 2022 | 365 | 0.170 |
Why?
| | Intestines | 3 | 2020 | 324 | 0.170 |
Why?
| | Sucrose | 3 | 2018 | 92 | 0.170 |
Why?
| | Deoxycytidine | 1 | 2020 | 137 | 0.160 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 160 | 0.160 |
Why?
| | SNARE Proteins | 1 | 2019 | 37 | 0.160 |
Why?
| | Electron Microscope Tomography | 1 | 2019 | 35 | 0.160 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 25 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 777 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2020 | 443 | 0.160 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2021 | 25 | 0.160 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 15 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 15 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 496 | 0.160 |
Why?
| | Ileum | 1 | 2019 | 92 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.160 |
Why?
| | Models, Animal | 2 | 2022 | 337 | 0.160 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 160 | 0.160 |
Why?
| | Altitude Sickness | 1 | 2020 | 129 | 0.160 |
Why?
| | Kupffer Cells | 1 | 2019 | 45 | 0.160 |
Why?
| | Leishmania major | 1 | 2018 | 6 | 0.160 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 7 | 0.160 |
Why?
| | Emphysema | 1 | 2019 | 105 | 0.160 |
Why?
| | Phenotype | 3 | 2023 | 2754 | 0.160 |
Why?
| | Adenocarcinoma | 3 | 2011 | 787 | 0.160 |
Why?
| | Plant Extracts | 1 | 2020 | 154 | 0.150 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 74 | 0.150 |
Why?
| | Nitric Oxide | 3 | 2020 | 814 | 0.150 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2088 | 0.150 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2019 | 180 | 0.150 |
Why?
| | Nanoparticles | 1 | 2022 | 308 | 0.150 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 271 | 0.150 |
Why?
| | Intestine, Small | 2 | 2020 | 121 | 0.150 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 14 | 0.150 |
Why?
| | Arteries | 1 | 2020 | 244 | 0.150 |
Why?
| | Cold Temperature | 1 | 2019 | 125 | 0.150 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 48 | 0.150 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 27 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2023 | 677 | 0.150 |
Why?
| | Protein Kinases | 1 | 2020 | 300 | 0.150 |
Why?
| | Pneumonia | 1 | 2023 | 561 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 68 | 0.150 |
Why?
| | Oxidation-Reduction | 5 | 2021 | 912 | 0.150 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 98 | 0.150 |
Why?
| | Insulin Resistance | 4 | 2019 | 1068 | 0.150 |
Why?
| | Hep G2 Cells | 4 | 2021 | 59 | 0.150 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 30 | 0.150 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 241 | 0.150 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 3 | 0.150 |
Why?
| | Intestinal Mucosa | 3 | 2016 | 528 | 0.140 |
Why?
| | Base Sequence | 6 | 2015 | 2080 | 0.140 |
Why?
| | Glucosides | 1 | 2018 | 36 | 0.140 |
Why?
| | Proteome | 2 | 2019 | 335 | 0.140 |
Why?
| | Relaxin | 1 | 2017 | 15 | 0.140 |
Why?
| | Transcription, Genetic | 3 | 2005 | 1282 | 0.140 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 59 | 0.140 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 33 | 0.140 |
Why?
| | Vasodilation | 1 | 2020 | 414 | 0.140 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 516 | 0.140 |
Why?
| | Virulence Factors | 1 | 2018 | 137 | 0.140 |
Why?
| | Sulfonamides | 1 | 2020 | 442 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 251 | 0.140 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.140 |
Why?
| | Disease Progression | 6 | 2020 | 2364 | 0.140 |
Why?
| | Phosgene | 1 | 2017 | 6 | 0.140 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 90 | 0.140 |
Why?
| | Cytochrome d Group | 1 | 2016 | 2 | 0.140 |
Why?
| | Temperature | 2 | 2018 | 557 | 0.140 |
Why?
| | Oximes | 1 | 2017 | 19 | 0.140 |
Why?
| | Cell Differentiation | 7 | 2020 | 1681 | 0.140 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2022 | 14 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 239 | 0.140 |
Why?
| | Cytochrome b Group | 1 | 2016 | 16 | 0.140 |
Why?
| | Metabolic Diseases | 1 | 2018 | 98 | 0.140 |
Why?
| | Spleen | 2 | 2018 | 480 | 0.140 |
Why?
| | DNA Primers | 5 | 2015 | 496 | 0.140 |
Why?
| | Sciuridae | 2 | 2023 | 142 | 0.140 |
Why?
| | Amino Acid Sequence | 6 | 2020 | 1956 | 0.140 |
Why?
| | Cells, Cultured | 10 | 2020 | 3802 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 670 | 0.130 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.130 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.130 |
Why?
| | Zebrafish | 1 | 2020 | 407 | 0.130 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 61 | 0.130 |
Why?
| | Necrosis | 2 | 2015 | 210 | 0.130 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 25 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 141 | 0.130 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 676 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 45 | 0.130 |
Why?
| | Metalloporphyrins | 2 | 2014 | 102 | 0.130 |
Why?
| | Mice, Obese | 3 | 2023 | 51 | 0.130 |
Why?
| | Homocystinuria | 1 | 2017 | 62 | 0.130 |
Why?
| | Salmonella enterica | 1 | 2016 | 51 | 0.130 |
Why?
| | Rabbits | 10 | 2002 | 713 | 0.130 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2530 | 0.130 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2148 | 0.130 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 636 | 0.130 |
Why?
| | Choline | 1 | 2017 | 106 | 0.130 |
Why?
| | Estradiol | 4 | 1988 | 450 | 0.130 |
Why?
| | Microbiota | 1 | 2023 | 646 | 0.130 |
Why?
| | Optical Imaging | 1 | 2016 | 51 | 0.130 |
Why?
| | Disease Susceptibility | 2 | 2020 | 314 | 0.130 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 1996 | 66 | 0.130 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1214 | 0.130 |
Why?
| | Biliary Atresia | 1 | 2018 | 186 | 0.130 |
Why?
| | Fibrosis | 4 | 2022 | 452 | 0.130 |
Why?
| | Acetylcysteine | 2 | 2022 | 141 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 786 | 0.130 |
Why?
| | Epithelium, Corneal | 1 | 2016 | 35 | 0.130 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 240 | 0.120 |
Why?
| | Peroxidase | 5 | 2015 | 160 | 0.120 |
Why?
| | MicroRNAs | 1 | 2021 | 598 | 0.120 |
Why?
| | Cell Division | 7 | 1988 | 745 | 0.120 |
Why?
| | Mice, Transgenic | 5 | 2021 | 1925 | 0.120 |
Why?
| | Epidermis | 2 | 2014 | 147 | 0.120 |
Why?
| | Down-Regulation | 4 | 2022 | 593 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 122 | 0.120 |
Why?
| | Pelvis | 1 | 2016 | 89 | 0.120 |
Why?
| | Space Flight | 1 | 2016 | 104 | 0.120 |
Why?
| | Skin Diseases | 1 | 2017 | 121 | 0.120 |
Why?
| | Diet | 3 | 2018 | 1076 | 0.120 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 470 | 0.120 |
Why?
| | Carcinogenesis | 3 | 2023 | 172 | 0.120 |
Why?
| | Chemokines | 3 | 2023 | 214 | 0.120 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2741 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 779 | 0.120 |
Why?
| | Interleukin-6 | 3 | 2023 | 661 | 0.120 |
Why?
| | Hematopoietic System | 1 | 2014 | 8 | 0.120 |
Why?
| | Breast Feeding | 1 | 2018 | 366 | 0.120 |
Why?
| | Cytoprotection | 2 | 2015 | 51 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 386 | 0.120 |
Why?
| | Alanine Transaminase | 4 | 2016 | 140 | 0.120 |
Why?
| | Vagina | 1 | 2016 | 146 | 0.120 |
Why?
| | Body Weight | 5 | 2016 | 853 | 0.120 |
Why?
| | Weight Loss | 1 | 2019 | 640 | 0.120 |
Why?
| | Motor Activity | 1 | 2019 | 623 | 0.110 |
Why?
| | Mice, Inbred ICR | 3 | 2021 | 108 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 592 | 0.110 |
Why?
| | Middle Aged | 9 | 2020 | 26552 | 0.110 |
Why?
| | Melanoma | 1 | 2020 | 620 | 0.110 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 20 | 0.110 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 8 | 0.110 |
Why?
| | Dermis | 1 | 2014 | 30 | 0.110 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 39 | 0.110 |
Why?
| | Cloning, Molecular | 4 | 2010 | 514 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 219 | 0.110 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 20 | 0.110 |
Why?
| | Stilbenes | 1 | 2013 | 36 | 0.110 |
Why?
| | Heart | 1 | 2017 | 609 | 0.110 |
Why?
| | Methylation | 1 | 2014 | 208 | 0.110 |
Why?
| | Metabolomics | 4 | 2022 | 508 | 0.110 |
Why?
| | Macrophage Activation | 3 | 2023 | 162 | 0.110 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 113 | 0.110 |
Why?
| | Phosphoproteins | 2 | 2013 | 291 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 2 | 2020 | 498 | 0.110 |
Why?
| | Grape Seed Extract | 1 | 2013 | 41 | 0.110 |
Why?
| | B-Lymphocytes | 1 | 2018 | 757 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 132 | 0.110 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1996 | 145 | 0.110 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 339 | 0.110 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 66 | 0.110 |
Why?
| | Organ Size | 4 | 2016 | 420 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 442 | 0.100 |
Why?
| | Isoproterenol | 1 | 2013 | 105 | 0.100 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 324 | 0.100 |
Why?
| | Lymphopenia | 1 | 2013 | 48 | 0.100 |
Why?
| | Inositol Phosphates | 3 | 1988 | 22 | 0.100 |
Why?
| | Green Fluorescent Proteins | 3 | 2011 | 365 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2013 | 59 | 0.100 |
Why?
| | Mothers | 2 | 2018 | 651 | 0.100 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2003 | 7 | 0.100 |
Why?
| | Microfilament Proteins | 1 | 2013 | 125 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 906 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 63 | 0.100 |
Why?
| | Testis | 1 | 1992 | 133 | 0.100 |
Why?
| | Carrier Proteins | 3 | 2017 | 685 | 0.100 |
Why?
| | Cattle | 6 | 2016 | 913 | 0.100 |
Why?
| | Perilipin-3 | 2 | 2008 | 2 | 0.100 |
Why?
| | Neurons | 1 | 2019 | 1261 | 0.100 |
Why?
| | Mammals | 2 | 2023 | 240 | 0.090 |
Why?
| | Arousal | 1 | 2012 | 143 | 0.090 |
Why?
| | DNA, Complementary | 3 | 2016 | 254 | 0.090 |
Why?
| | Fructose-Bisphosphate Aldolase | 2 | 2023 | 7 | 0.090 |
Why?
| | Eye Proteins | 2 | 2021 | 69 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.090 |
Why?
| | Mutation | 3 | 2020 | 3313 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 41 | 0.090 |
Why?
| | Administration, Cutaneous | 3 | 2017 | 116 | 0.090 |
Why?
| | Ligands | 2 | 2023 | 553 | 0.090 |
Why?
| | Nasal Cavity | 1 | 2011 | 46 | 0.090 |
Why?
| | Microtubules | 1 | 2013 | 234 | 0.090 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 60 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 4880 | 0.090 |
Why?
| | Acetaldehyde | 1 | 2010 | 15 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 217 | 0.090 |
Why?
| | Chenodeoxycholic Acid | 2 | 2021 | 12 | 0.090 |
Why?
| | Luminescent Proteins | 2 | 2001 | 165 | 0.090 |
Why?
| | Glycolysis | 2 | 2021 | 223 | 0.090 |
Why?
| | Pregnancy | 6 | 2020 | 5490 | 0.090 |
Why?
| | Heme Oxygenase-1 | 2 | 2021 | 51 | 0.080 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1136 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 914 | 0.080 |
Why?
| | Multidrug Resistance-Associated Proteins | 2 | 2021 | 34 | 0.080 |
Why?
| | Casein Kinase II | 1 | 2009 | 21 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 599 | 0.080 |
Why?
| | COS Cells | 2 | 2003 | 173 | 0.080 |
Why?
| | Hypertension | 1 | 2017 | 1051 | 0.080 |
Why?
| | Protein Folding | 1 | 2011 | 239 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 6189 | 0.080 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 51 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 4 | 2016 | 2139 | 0.080 |
Why?
| | Peroxiredoxin VI | 1 | 2009 | 5 | 0.080 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 90 | 0.080 |
Why?
| | Viral Envelope Proteins | 1 | 2009 | 73 | 0.080 |
Why?
| | Lysosomes | 2 | 2019 | 123 | 0.080 |
Why?
| | Serine | 1 | 2009 | 124 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 43 | 0.080 |
Why?
| | Organ Specificity | 3 | 2018 | 262 | 0.080 |
Why?
| | Oleic Acid | 1 | 2008 | 29 | 0.080 |
Why?
| | Exosomes | 1 | 2009 | 92 | 0.080 |
Why?
| | Structure-Activity Relationship | 2 | 2008 | 497 | 0.070 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2019 | 91 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2008 | 95 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2019 | 139 | 0.070 |
Why?
| | Tissue Distribution | 3 | 2007 | 280 | 0.070 |
Why?
| | Adiposity | 2 | 2015 | 458 | 0.070 |
Why?
| | Adult | 9 | 2020 | 30245 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 2 | 2020 | 283 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 8606 | 0.070 |
Why?
| | Muscle, Smooth | 2 | 2019 | 143 | 0.070 |
Why?
| | Vasotocin | 1 | 2006 | 5 | 0.070 |
Why?
| | Affinity Labels | 3 | 1992 | 25 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 32 | 0.070 |
Why?
| | Urethane | 1 | 2007 | 40 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2020 | 834 | 0.070 |
Why?
| | Neoplasm Invasiveness | 2 | 2020 | 435 | 0.070 |
Why?
| | Muscle Tonus | 1 | 2006 | 17 | 0.070 |
Why?
| | Lipogenesis | 2 | 2018 | 56 | 0.070 |
Why?
| | Uterine Contraction | 1 | 2006 | 17 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 625 | 0.070 |
Why?
| | Prostaglandins | 1 | 2006 | 77 | 0.070 |
Why?
| | Sugar Phosphates | 1 | 1986 | 2 | 0.070 |
Why?
| | Lizards | 1 | 2006 | 34 | 0.070 |
Why?
| | Azides | 3 | 1992 | 44 | 0.070 |
Why?
| | Nitric Oxide Synthase Type II | 3 | 2014 | 156 | 0.070 |
Why?
| | Thermodynamics | 1 | 2008 | 378 | 0.070 |
Why?
| | Acetylation | 2 | 2017 | 208 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2010 | 386 | 0.060 |
Why?
| | Amidinotransferases | 2 | 2016 | 2 | 0.060 |
Why?
| | Guanidinoacetate N-Methyltransferase | 2 | 2016 | 5 | 0.060 |
Why?
| | S-Adenosylhomocysteine | 2 | 2016 | 24 | 0.060 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 100 | 0.060 |
Why?
| | DNA Replication | 1 | 1987 | 200 | 0.060 |
Why?
| | Bone Marrow | 1 | 2007 | 242 | 0.060 |
Why?
| | Aged | 6 | 2023 | 18944 | 0.060 |
Why?
| | Feces | 2 | 2020 | 369 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2018 | 387 | 0.060 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 14 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 167 | 0.060 |
Why?
| | S-Adenosylmethionine | 2 | 2016 | 54 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1570 | 0.060 |
Why?
| | Diabetes Mellitus | 2 | 2018 | 896 | 0.060 |
Why?
| | Transcription Factors | 3 | 2019 | 1497 | 0.060 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 435 | 0.060 |
Why?
| | Adenoma | 1 | 2007 | 187 | 0.060 |
Why?
| | Perilipin-1 | 2 | 2019 | 16 | 0.060 |
Why?
| | Homocysteine | 2 | 2016 | 137 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2018 | 568 | 0.060 |
Why?
| | Edema | 2 | 2017 | 119 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2016 | 366 | 0.060 |
Why?
| | Tamoxifen | 2 | 2020 | 190 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 1998 | 984 | 0.060 |
Why?
| | Cyclic GMP | 2 | 2019 | 78 | 0.060 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1510 | 0.060 |
Why?
| | Diet, Fat-Restricted | 2 | 2015 | 73 | 0.060 |
Why?
| | Time Factors | 5 | 2015 | 6032 | 0.060 |
Why?
| | Poly Adenosine Diphosphate Ribose | 1 | 2023 | 2 | 0.060 |
Why?
| | Cyclooxygenase 2 | 2 | 2015 | 161 | 0.060 |
Why?
| | Macrophages, Alveolar | 1 | 2007 | 341 | 0.060 |
Why?
| | Glycoside Hydrolases | 1 | 2023 | 30 | 0.060 |
Why?
| | Mammary Glands, Human | 2 | 2016 | 59 | 0.050 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 12 | 0.050 |
Why?
| | Genes, Regulator | 1 | 2023 | 33 | 0.050 |
Why?
| | Acute-Phase Reaction | 1 | 2023 | 39 | 0.050 |
Why?
| | Furosemide | 1 | 2023 | 32 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 344 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2023 | 62 | 0.050 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 22 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 47 | 0.050 |
Why?
| | Cell Survival | 4 | 2014 | 1004 | 0.050 |
Why?
| | Antigens, CD | 2 | 2005 | 437 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 162 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 149 | 0.050 |
Why?
| | Chemokine CCL7 | 1 | 2022 | 2 | 0.050 |
Why?
| | Buthionine Sulfoximine | 1 | 2022 | 7 | 0.050 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 15 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2023 | 137 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 176 | 0.050 |
Why?
| | Cervix Uteri | 1 | 2002 | 43 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 1822 | 0.050 |
Why?
| | Rats, Inbred F344 | 2 | 1992 | 234 | 0.050 |
Why?
| | Fluorine | 2 | 1992 | 15 | 0.050 |
Why?
| | Homeostasis | 2 | 2016 | 561 | 0.050 |
Why?
| | Adenovirus E1A Proteins | 1 | 2001 | 11 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 16 | 0.050 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.050 |
Why?
| | Dysbiosis | 1 | 2023 | 144 | 0.050 |
Why?
| | Adenoviruses, Human | 1 | 2001 | 24 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 349 | 0.050 |
Why?
| | Sodium Glutamate | 1 | 2021 | 6 | 0.050 |
Why?
| | Immune Sera | 2 | 1992 | 77 | 0.050 |
Why?
| | Heme | 1 | 2021 | 52 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 21 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 33 | 0.050 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 144 | 0.050 |
Why?
| | PAX6 Transcription Factor | 1 | 2021 | 17 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 68 | 0.050 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2002 | 100 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 58 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 88 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1110 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2022 | 88 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 50 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 93 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 137 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 118 | 0.050 |
Why?
| | Cation Exchange Resins | 1 | 2001 | 7 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2001 | 80 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 126 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1286 | 0.050 |
Why?
| | Histological Techniques | 1 | 2021 | 40 | 0.050 |
Why?
| | Polylysine | 1 | 2001 | 17 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 171 | 0.050 |
Why?
| | Drinking | 1 | 2021 | 30 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2023 | 360 | 0.050 |
Why?
| | Calcium | 1 | 2006 | 1086 | 0.050 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 133 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2001 | 99 | 0.050 |
Why?
| | Plant Oils | 1 | 2000 | 26 | 0.040 |
Why?
| | Intestine, Large | 1 | 2020 | 13 | 0.040 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 20 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 31 | 0.040 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 2690 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 268 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 20 | 0.040 |
Why?
| | Morphogenesis | 1 | 2021 | 151 | 0.040 |
Why?
| | Fluorescence | 1 | 2001 | 148 | 0.040 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2020 | 14 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 68 | 0.040 |
Why?
| | Receptors, Purinergic P2X3 | 1 | 2020 | 14 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.040 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 7 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 169 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 298 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 166 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 570 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 144 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 24 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 605 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 31 | 0.040 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 80 | 0.040 |
Why?
| | Cytomegalovirus | 1 | 2001 | 140 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 50 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 26 | 0.040 |
Why?
| | Ki-67 Antigen | 2 | 2016 | 101 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 18 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 167 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 103 | 0.040 |
Why?
| | Binding Sites | 1 | 2003 | 1153 | 0.040 |
Why?
| | Polymers | 2 | 2014 | 448 | 0.040 |
Why?
| | Purines | 1 | 2020 | 158 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 108 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2020 | 143 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 364 | 0.040 |
Why?
| | Protein Binding | 3 | 2011 | 1867 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 184 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2002 | 208 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 108 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 27 | 0.040 |
Why?
| | Food Preferences | 1 | 2020 | 108 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2010 | 1842 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 104 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2019 | 61 | 0.040 |
Why?
| | Photoperiod | 1 | 2019 | 45 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 944 | 0.040 |
Why?
| | Leishmania donovani | 1 | 2018 | 3 | 0.040 |
Why?
| | Parasite Load | 1 | 2018 | 7 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2003 | 652 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 185 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 31 | 0.040 |
Why?
| | beta Catenin | 1 | 2020 | 208 | 0.040 |
Why?
| | gamma Catenin | 1 | 2018 | 11 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 86 | 0.040 |
Why?
| | Desmoglein 3 | 1 | 2018 | 17 | 0.040 |
Why?
| | Metaplasia | 1 | 2018 | 54 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 146 | 0.040 |
Why?
| | Bronchial Diseases | 1 | 2018 | 34 | 0.040 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2019 | 168 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 51 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 77 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 386 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 63 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 71 | 0.040 |
Why?
| | Adiponectin | 2 | 2013 | 209 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 693 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 85 | 0.040 |
Why?
| | Inhibitor of Apoptosis Proteins | 3 | 2003 | 42 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 95 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 17 | 0.040 |
Why?
| | Virulence | 1 | 2018 | 228 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 217 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 24 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 361 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 172 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2003 | 728 | 0.040 |
Why?
| | Models, Molecular | 2 | 2013 | 1359 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.040 |
Why?
| | Bacteria | 1 | 2023 | 716 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 61 | 0.040 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2017 | 1 | 0.040 |
Why?
| | Isoenzymes | 1 | 2018 | 273 | 0.040 |
Why?
| | Neutrophils | 1 | 2022 | 1072 | 0.040 |
Why?
| | Urinalysis | 1 | 2017 | 65 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 20 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 426 | 0.030 |
Why?
| | Podocytes | 1 | 2017 | 44 | 0.030 |
Why?
| | DNA | 5 | 1986 | 1331 | 0.030 |
Why?
| | Blood Glucose | 2 | 2018 | 1823 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 153 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 161 | 0.030 |
Why?
| | Immunoenzyme Techniques | 2 | 2011 | 191 | 0.030 |
Why?
| | Erythema | 1 | 2017 | 26 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 460 | 0.030 |
Why?
| | Bronchi | 1 | 2018 | 222 | 0.030 |
Why?
| | Staining and Labeling | 2 | 1992 | 133 | 0.030 |
Why?
| | Indomethacin | 2 | 2006 | 70 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 164 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 469 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 342 | 0.030 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.030 |
Why?
| | Intracellular Membranes | 1 | 2016 | 70 | 0.030 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1996 | 4 | 0.030 |
Why?
| | Okadaic Acid | 1 | 1996 | 11 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1996 | 48 | 0.030 |
Why?
| | Aspartate Aminotransferases | 1 | 2016 | 84 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2016 | 89 | 0.030 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 10 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 275 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 36 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1634 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 925 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1996 | 147 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 783 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 769 | 0.030 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 47 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 45 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1996 | 88 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 54 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1733 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2016 | 136 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 201 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1725 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2015 | 26 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2017 | 293 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 476 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 40 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 257 | 0.030 |
Why?
| | Catalysis | 1 | 2016 | 288 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 25 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 595 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1024 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1065 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 543 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 324 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 23 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 558 | 0.030 |
Why?
| | Comet Assay | 1 | 2014 | 18 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 351 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 81 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 34 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 310 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 291 | 0.030 |
Why?
| | Kinetics | 3 | 1987 | 1528 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 132 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 88 | 0.030 |
Why?
| | Progesterone | 2 | 1987 | 230 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 426 | 0.030 |
Why?
| | Skinfold Thickness | 1 | 2013 | 49 | 0.030 |
Why?
| | Computational Biology | 1 | 2017 | 527 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2016 | 375 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1996 | 716 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2013 | 117 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 719 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2014 | 114 | 0.030 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 80 | 0.030 |
Why?
| | Tetraspanin 28 | 2 | 2005 | 4 | 0.030 |
Why?
| | Cell Nucleus | 2 | 2009 | 527 | 0.030 |
Why?
| | Tongue | 1 | 2013 | 67 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1992 | 192 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1996 | 666 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 5032 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 63 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 23 | 0.030 |
Why?
| | Ketone Bodies | 1 | 2013 | 15 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 479 | 0.030 |
Why?
| | Leydig Cells | 1 | 1992 | 11 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4384 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2016 | 521 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 24 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1465 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2016 | 459 | 0.030 |
Why?
| | Antigens, CD1d | 1 | 2013 | 63 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1705 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 354 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1993 | 174 | 0.030 |
Why?
| | Theca Cells | 1 | 1992 | 1 | 0.030 |
Why?
| | Models, Biological | 2 | 2011 | 1589 | 0.030 |
Why?
| | Actins | 1 | 2014 | 373 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3318 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 453 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 531 | 0.030 |
Why?
| | Models, Chemical | 1 | 2014 | 246 | 0.030 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 443 | 0.020 |
Why?
| | Insulin | 2 | 2016 | 2076 | 0.020 |
Why?
| | Caseins | 1 | 2011 | 18 | 0.020 |
Why?
| | Body Temperature | 1 | 2012 | 176 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 463 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2011 | 37 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 752 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1203 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 137 | 0.020 |
Why?
| | Lipase | 1 | 2011 | 55 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1521 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1872 | 0.020 |
Why?
| | Retinal Dehydrogenase | 1 | 2011 | 33 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 62 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 919 | 0.020 |
Why?
| | Tritium | 1 | 1990 | 66 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 79 | 0.020 |
Why?
| | Cations, Divalent | 1 | 1990 | 51 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Histones | 1 | 2015 | 528 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 2010 | 67 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 132 | 0.020 |
Why?
| | Insecta | 1 | 2010 | 62 | 0.020 |
Why?
| | NAD | 1 | 2010 | 63 | 0.020 |
Why?
| | Hydrolysis | 1 | 1990 | 172 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 131 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 320 | 0.020 |
Why?
| | Oxidants | 1 | 2010 | 106 | 0.020 |
Why?
| | Seasons | 1 | 2012 | 437 | 0.020 |
Why?
| | Cytosol | 1 | 2010 | 199 | 0.020 |
Why?
| | HeLa Cells | 2 | 2001 | 553 | 0.020 |
Why?
| | Transgenes | 1 | 2010 | 169 | 0.020 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2009 | 28 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1990 | 96 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 633 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 996 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2009 | 103 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 334 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2009 | 67 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1417 | 0.020 |
Why?
| | Prostaglandins F, Synthetic | 1 | 1989 | 9 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 48 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 584 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2008 | 94 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 137 | 0.020 |
Why?
| | Administration, Oral | 1 | 2010 | 719 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 423 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 326 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 1617 | 0.020 |
Why?
| | Cell Movement | 2 | 2009 | 852 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 519 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 16 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 271 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6296 | 0.020 |
Why?
| | Reflex, Stretch | 1 | 2006 | 9 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 53 | 0.020 |
Why?
| | Infant | 1 | 2019 | 7922 | 0.020 |
Why?
| | Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1986 | 3 | 0.020 |
Why?
| | Vanadium | 1 | 1986 | 4 | 0.020 |
Why?
| | Vanadates | 1 | 1986 | 13 | 0.020 |
Why?
| | Carbachol | 1 | 1986 | 19 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 321 | 0.020 |
Why?
| | Prostaglandins E | 1 | 1986 | 44 | 0.020 |
Why?
| | Thymidine | 1 | 1986 | 57 | 0.020 |
Why?
| | Growth Substances | 1 | 1986 | 136 | 0.020 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1986 | 44 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 349 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2009 | 519 | 0.020 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1986 | 81 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1208 | 0.020 |
Why?
| | PPAR gamma | 1 | 2007 | 179 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 1986 | 160 | 0.020 |
Why?
| | Tetraspanins | 1 | 2005 | 14 | 0.020 |
Why?
| | Dinoprostone | 1 | 1986 | 178 | 0.020 |
Why?
| | Detergents | 1 | 2005 | 40 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1986 | 222 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 102 | 0.020 |
Why?
| | Uteroglobin | 2 | 1984 | 16 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1987 | 267 | 0.020 |
Why?
| | Solubility | 1 | 2005 | 221 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 9093 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2077 | 0.010 |
Why?
| | Introns | 1 | 2005 | 227 | 0.010 |
Why?
| | Multiprotein Complexes | 1 | 2005 | 140 | 0.010 |
Why?
| | Metformin | 1 | 2007 | 273 | 0.010 |
Why?
| | Testosterone | 1 | 1987 | 341 | 0.010 |
Why?
| | Glucagon | 1 | 2003 | 92 | 0.010 |
Why?
| | Aging | 1 | 1992 | 1601 | 0.010 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2005 | 196 | 0.010 |
Why?
| | Fibroblasts | 1 | 2007 | 827 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 2 | 1979 | 157 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 43 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2002 | 39 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 285 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2002 | 100 | 0.010 |
Why?
| | Mucous Membrane | 1 | 2002 | 108 | 0.010 |
Why?
| | Photochemistry | 2 | 1992 | 123 | 0.010 |
Why?
| | Sheep | 3 | 1992 | 760 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1979 | 297 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2000 | 29 | 0.010 |
Why?
| | Gestational Age | 1 | 2003 | 762 | 0.010 |
Why?
| | Molecular Structure | 2 | 1992 | 429 | 0.010 |
Why?
| | Polyribosomes | 1 | 1980 | 22 | 0.010 |
Why?
| | Keratins | 1 | 2001 | 163 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17724 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 163 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 194 | 0.010 |
Why?
| | DNA, Viral | 1 | 2002 | 345 | 0.010 |
Why?
| | Thyrotropin | 1 | 1980 | 100 | 0.010 |
Why?
| | Thyroid Gland | 1 | 1980 | 85 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1979 | 24 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1006 | 0.010 |
Why?
| | Child | 1 | 2018 | 18340 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 697 | 0.010 |
Why?
| | Chromomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Olivomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Plicamycin | 1 | 1978 | 3 | 0.010 |
Why?
| | Papillomavirus Infections | 1 | 2002 | 258 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1978 | 252 | 0.010 |
Why?
| | Cell Cycle | 1 | 1978 | 538 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2000 | 557 | 0.010 |
Why?
| | RNA | 1 | 1980 | 801 | 0.010 |
Why?
| | Luteal Cells | 1 | 1992 | 2 | 0.010 |
Why?
| | Esters | 1 | 1992 | 62 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 37 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1989 | 77 | 0.000 |
Why?
| | Estrogen Antagonists | 1 | 1984 | 39 | 0.000 |
Why?
| | Poly A | 1 | 1980 | 45 | 0.000 |
Why?
| | RNA, Ribosomal | 1 | 1980 | 157 | 0.000 |
Why?
| | Fixatives | 1 | 1978 | 15 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1978 | 27 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1978 | 163 | 0.000 |
Why?
| | Cricetinae | 1 | 1978 | 244 | 0.000 |
Why?
| | Magnesium | 1 | 1978 | 144 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1978 | 502 | 0.000 |
Why?
|
|
Orlicky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|